212 related articles for article (PubMed ID: 35688948)
1. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
Ou Q; Dou X; Tang J; Wu P; Pan D
Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
[TBL] [Abstract][Full Text] [Related]
2. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
[TBL] [Abstract][Full Text] [Related]
3. Extracellular vesicles produced by bone marrow mesenchymal stem cells overexpressing programmed death-ligand 1 ameliorate dextran sodium sulfate-induced ulcerative colitis in rats by regulating Th17/Treg cell balance through PTEN/PI3K/AKT/mTOR axis.
He H; Chen Q; Fan H; Leng XY; Zhu F; Gao F; Zhou Q; Dong Y; Yang J
J Gastroenterol Hepatol; 2022 Dec; 37(12):2243-2254. PubMed ID: 36044618
[TBL] [Abstract][Full Text] [Related]
4. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
Li M; Soder R; Abhyankar S; Abdelhakim H; Braun MW; Trinidad CV; Pathak HB; Pessetto Z; Deighan C; Ganguly S; Dawn B; McGuirk J; Dunavin N; Godwin AK
J Extracell Vesicles; 2021 Feb; 10(4):e12067. PubMed ID: 33598108
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes.
Xu K; Ma D; Zhang G; Gao J; Su Y; Liu S; Liu Y; Han J; Tian M; Wei C; Zhang L
Mol Immunol; 2021 Jul; 135():36-44. PubMed ID: 33857817
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cell-Derived Extracellular Vesicles with High PD-L1 Expression for Autoimmune Diseases Treatment.
Xu F; Fei Z; Dai H; Xu J; Fan Q; Shen S; Zhang Y; Ma Q; Chu J; Peng F; Zhou F; Liu Z; Wang C
Adv Mater; 2022 Jan; 34(1):e2106265. PubMed ID: 34613627
[TBL] [Abstract][Full Text] [Related]
7. Vascularized composite allograft rejection is delayed by infusion of IFN-γ-conditioned BMSCs through upregulating PD-L1.
Wang Y; Xi Y; Han F; Liu Y; Li N; Ren Z; Xue J; Guo L; Hu D
Cell Tissue Res; 2019 May; 376(2):211-220. PubMed ID: 30613905
[TBL] [Abstract][Full Text] [Related]
8. MSC-Derived Small Extracellular Vesicles Attenuate Autoimmune Dacryoadenitis by Promoting M2 Macrophage Polarization and Inducing Tregs
Li N; Gao Z; Zhao L; Du B; Ma B; Nian H; Wei R
Front Immunol; 2022; 13():888949. PubMed ID: 35874782
[TBL] [Abstract][Full Text] [Related]
9. Effect of small extracellular vesicles derived from IL-10-overexpressing mesenchymal stem cells on experimental autoimmune uveitis.
Li Y; Ren X; Zhang Z; Duan Y; Li H; Chen S; Shao H; Li X; Zhang X
Stem Cell Res Ther; 2022 Mar; 13(1):100. PubMed ID: 35255957
[TBL] [Abstract][Full Text] [Related]
10. Donor BMSC-derived small extracellular vesicles relieve acute rejection post-renal allograft through transmitting Loc108349490 to dendritic cells.
Wang ZG; Xu HE; Cheng FM; Zhang J; Feng YH; Liu DH; Shang WJ; Feng GW
Aging Cell; 2021 Oct; 20(10):e13461. PubMed ID: 34499402
[TBL] [Abstract][Full Text] [Related]
11. High-throughput RNA-sequencing identifies mesenchymal stem cell-induced immunological signature in a rat model of corneal allograft rejection.
Lu X; Chu C; Liu X; Gao Y; Wu M; Guo F; Li Y; Geng C; Huang Y; Zhang Y; Zhao S
PLoS One; 2019; 14(9):e0222515. PubMed ID: 31545822
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In Vivo.
Lynch K; Treacy O; Chen X; Murphy N; Lohan P; Islam MN; Donohoe E; Griffin MD; Watson L; McLoughlin S; O'Malley G; Ryan AE; Ritter T
Mol Ther; 2020 Sep; 28(9):2023-2043. PubMed ID: 32531237
[TBL] [Abstract][Full Text] [Related]
13. Immunological priming of mesenchymal stromal/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease
Hackel A; Vollmer S; Bruderek K; Lang S; Brandau S
Front Immunol; 2023; 14():1078551. PubMed ID: 36875112
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway.
Chen D; Tang P; Liu L; Wang F; Xing H; Sun L; Jiang Z
Cell Cycle; 2018; 17(7):858-867. PubMed ID: 29493401
[TBL] [Abstract][Full Text] [Related]
15. Human Umbilical Cord Mesenchymal Stem Cells Promote Macrophage PD-L1 Expression and Attenuate Acute Lung Injury in Mice.
Tu C; Wang Z; Xiang E; Zhang Q; Zhang Y; Wu P; Li C; Wu D
Curr Stem Cell Res Ther; 2022; 17(6):564-575. PubMed ID: 35086457
[TBL] [Abstract][Full Text] [Related]
16. Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury.
Nakazaki M; Morita T; Lankford KL; Askenase PW; Kocsis JD
J Extracell Vesicles; 2021 Sep; 10(11):e12137. PubMed ID: 34478241
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Curative Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells and Their Small Extracellular Vesicles in Treating Osteoarthritis.
Tang S; Chen P; Zhang H; Weng H; Fang Z; Chen C; Peng G; Gao H; Hu K; Chen J; Chen L; Chen X
Int J Nanomedicine; 2021; 16():8185-8202. PubMed ID: 34938076
[TBL] [Abstract][Full Text] [Related]
18. Small Extracellular Vesicles Harboring PD-L1 in Obstructive Sleep Apnea.
Recoquillon S; Ali S; Justeau G; Riou J; Martinez MC; Andriantsitohaina R; Gagnadoux F; Trzepizur W
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542182
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
Jung D; Shin S; Kang SM; Jung I; Ryu S; Noh S; Choi SJ; Jeong J; Lee BY; Kim KS; Kim CS; Yoon JH; Lee CH; Bucher F; Kim YN; Im SH; Song BJ; Yea K; Baek MC
J Extracell Vesicles; 2022 Dec; 11(12):e12287. PubMed ID: 36447429
[TBL] [Abstract][Full Text] [Related]
20. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
